"Grade as assessed by the International Medullary Thyroid Carcinoma Grading System IMTCGS is not only prognostic but also reproducible"
Check out our publication in Endocrine Pathology, hot off the press!
https://t.co/GYO5dmSsN7
#endocrinepathology#springer#mtc#pathology
Happy New Year! Check out the January issue of LI.
https://t.co/R4YpuSD2Hk
🔸Mother-to-child transmission of HBV
🔸Advanced detection strategies for cardiotropic virus infection
🔸Bioglass promotes wound healing
and much more
We had a big year in 2021, as exemplified by a few of our favorite numbers that we’ve rounded up! We’re tremendously proud of the work we’ve done for patients and the team we’ve built to keep driving our mission forward. Here’s to 2022 and growing these numbers!
We are partnering with @AkoyaBio ! This new partnership combines PathAI’s AI-based platforms with Akoya’s Phenoptics™ spatial phenotyping platform to provide a complete spatial biology solution for biomarker-guided drug development.
https://t.co/xhJQMNgpfW
In case you missed us at AASLD’s #LiverMTG21, catch our latest data collaborations around AI-scoring with @bmsnews & Novo Nordisk. See highlights below and view the full posters here: https://t.co/HyyFmfdD44, https://t.co/0hWKyTlieB
PathAI is excited to present our new research in AI-based UC models at #IBDInnovate hosted by @CrohnsColitisFn. If you are attending the conference, catch our presentation tomorrow at 3:45 ET!